RAC 3.01% $1.45 race oncology ltd

General Comments / Chat, page-8890

  1. 95 Posts.
    lightbulb Created with Sketch. 91
    Please share your response? But I doubt there will be much substance and I agree, much is asked from us retail shareholders. There's still so many questions that we're seemingly expected to just accept with no answer for: all the board changes, seeming dismissal of the funded SPP plan, strategic updates signed off by the board then killed in a few weeks...

    Race needs to get a clear plan and stick to it. This period of turmoil can be all a non-issue if we finally get a solid plan to get the necessary clinical data PLUS a clear plan to commericalise. Until then, we're stuck with no clarity on strategy, time frames, funding. It's time to get on with it and go back to giving us clear communication.

    IMO
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.